Zinzino group revenue increased with a total of 14 %, compared with the previous year.

 

The revenue in May for Zinzino's sales markets increased by 14 % and amounted to SEK 312.2 (273.7) million. Faun Pharma's external sales amounted to SEK 3.9 (3.9) million. Overall, the Group increased revenues by 14 % to SEK 316.1 (277.6) million compared with the previous year.

Accumulated revenue for January – May 2026 increased by 23 % to SEK 1,545.9 (1,254.0) million.

 

Revenues were distributed as follows:

Regions,MSEK	26-May	25-May	Change	YTD 2026	YTD 2025	Change
The Nordics	26.2	29.5	-11%	129.4	129.8	0%
Central Europe	99.2	72.8	36%	464.4	333.9	39%
East Europe	30.1	36.3	-17%	141.6	160.6	-12%
South & West Europe	51.1	47.6	7%	258.5	216.4	19%
The Baltics	9.2	11.3	-19%	48.1	48.6	-1%
North America	66.6	46.1	44%	329.3	207.9	58%
South America	3.6	0.8	350%	18.7	3.9	379%
Asia-Pacific	24.1	27.4	-12%	117.2	118.4	-1%
Africa	2.1	1.9	11%	10.5	8.4	25%
Zinzino	312.2	273.7	14%	1,517.7	1,227.9	24%
Faun Pharma	3.9	3.9	0%	28.2	26.1	8%
Zinzino Group	316.1	277.6	14%	1,545.9	1,254.0	23%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: Tapper Partners AB